---
title: "Chemed President, CEO Sold Shares Worth Over $1.0M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296799234.md"
description: "Kevin J. McNamara, President and CEO of Chemed, sold 2,000 shares on August 21, 2026, at a weighted average price of $541.16 per share. The total transaction value was $1,082,320. Following this sale, McNamara directly holds 70,418 shares in the company."
datetime: "2026-08-24T13:50:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296799234.md)
  - [en](https://longbridge.com/en/news/296799234.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296799234.md)
generator: "portal-rs"
---

# Chemed President, CEO Sold Shares Worth Over $1.0M

Kevin J. McNamara, an insider director serving as president and CEO, reported a sale of company capital stock on August 21, 2026. The filing reports a weighted average selling price of $541.16 per share. The total sale amount reported was $1,082,320. McNamara disposed of 2,000 shares in the transaction. After the sale, he directly owns 70,418 shares of the company.

Reporter Name

Mcnamara Kevin J

Relationship

president and CEO

Type

Sell

Amount

$1,082,320

SEC Filing

Form 4

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [CHE.US](https://longbridge.com/en/quote/CHE.US.md)

## Related News & Research

- [Chemed (NYSE:CHE)  Shares Down 4.9%   - What's Next?](https://longbridge.com/en/news/297218220.md)
- [Chemed (NYSE:CHE) Posts Earnings Results](https://longbridge.com/en/news/294127496.md)
- [Structure Therapeutics CSO Lin Xichen reports disposal of common shares worth $275,830.34](https://longbridge.com/en/news/297845317.md)
- [Newmont boosts Solitario stake to 8,894,911 shares, or about 9.4%](https://longbridge.com/en/news/297915048.md)
- [SEA (NYSE:SE) COO Sells 20,000 Shares](https://longbridge.com/en/news/297895873.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**